We are live on
!
Find out more
C
Chescapmanager Portfolio holdings
AUM
$1.12B
1-Year Est. Return
67.49%
This Fund
S&P 500
This Quarter
Est. Return
+12.58%
1 Year Est. Return
+67.49%
3 Year Est. Return
+215.18%
5 Year Est. Return
+141.46%
10 Year Est. Return
–
AUM
$680M
AUM Growth
-$22.8M
(-3.2%)
Cap. Flow
-$76.3M
Cap. Flow
% of AUM
-11.23%
Top 10 Holdings %
Top 10 Hldgs %
66.57%
Holding
38
New
6
Increased
8
Reduced
4
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$20.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$19.5M |
| 3 |
Dollar Tree
DLTR
|
+$9.97M |
| 4 |
Theravance Biopharma
TBPH
|
+$6.83M |
| 5 |
DISH
DISH Network Corp.
DISH
|
+$3.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$28.4M |
| 2 |
Eagle Materials
EXP
|
+$10.2M |
| 3 |
PVT
Pivotal Acquisition Corp.
PVT
|
+$9.1M |
| 4 |
Cigna
CI
|
+$1.83M |
| 5 |
Newell Brands
NWL
|
+$1.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.86% |
| 2 | Consumer Discretionary | 16.78% |
| 3 | Industrials | 6.33% |
| 4 | Communication Services | 6% |
| 5 | Consumer Staples | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $161M | 23.66% |
500,000
| – | – |
|
|
CRON
2
Cronos Group
CRON
$1.07B
| $68.1M | 10.01% |
8,873,890
+381,663
| +4% | +$2.92M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $37.7M | 5.54% |
197,000
| – | – |
|
4
WillScot Mobile Mini Holdings
WSC
$4.84B
| $34M | 5% |
1,837,306
| – | – |
|
5
MGM Resorts International
MGM
$11.8B
| $29.2M | 4.3% |
878,052
-10,000
| -1% | -$305K |
|
6
Amazon
AMZN
$2.5T
| $27.7M | 4.08% |
300,000
+40,000
| +15% | +$3.54M |
|
7
Alphabet (Google) Class A
GOOGL
$4.01T
| $25.4M | 3.74% |
380,000
| – | – |
|
|
8
Theravance Biopharma
TBPH
$875M
| $24.6M | 3.61% |
949,006
+351,422
| +59% | +$6.83M |
|
|
TIF
9
DELISTED
Tiffany & Co.
TIF
| $22.7M | 3.34% |
+170,000
| New | +$20.1M |
|
|
10
Cigna
CI
$77.1B
| $22.4M | 3.3% |
109,693
-10,000
| -8% | -$1.83M |
|
|
11
Bristol-Myers Squibb
BMY
$128B
| $21.9M | 3.22% |
+340,852
| New | +$19.5M |
|
12
Nomad Foods
NOMD
$1.68B
| $21.9M | 3.22% |
978,043
+52,461
| +6% | +$1.07M |
|
|
TVRD
13
Tvardi Therapeutics
TVRD
$23.4M
| $20.9M | 3.08% |
36,103
+1,597
| +5% | +$1.12M |
|
14
Centene
CNC
$31.6B
| $20.9M | 3.08% |
332,777
| – | – |
|
|
CZR
15
DELISTED
Caesars Entertainment Corporation
CZR
| $20.3M | 2.99% |
1,494,458
| – | – |
|
|
16
Eagle Materials
EXP
$6.7B
| $17.5M | 2.58% |
193,425
-111,646
| -37% | -$10.2M |
|
17
Vail Resorts
MTN
$5.3B
| $14.4M | 2.12% |
60,000
| – | – |
|
|
DISH
18
CALL
DELISTED
DISH Network Corp.
DISH
| $11M | 1.62% |
310,000
| – | – |
|
19
PENN Entertainment
PENN
$2.83B
| $10.1M | 1.48% |
394,289
| – | – |
|
|
DISH
20
DELISTED
DISH Network Corp.
DISH
| $9.75M | 1.43% |
274,969
+105,569
| +62% | +$3.66M |
|
|
21
Dollar Tree
DLTR
$24B
| $8.94M | 1.31% |
+95,000
| New | +$9.97M |
|
22
Axalta
AXTA
$7.24B
| $8.84M | 1.3% |
290,691
| – | – |
|
|
NLSN
23
DELISTED
Nielsen Holdings plc
NLSN
| $8.64M | 1.27% |
425,610
| – | – |
|
24
Caesars Entertainment
CZR
$6.11B
| $7.16M | 1.05% |
120,000
| – | – |
|
|
25
CALL
Caesars Entertainment
CZR
$6.11B
| $5.96M | 0.88% |
100,000
| – | – |
|
Similar funds
CT
CNC
PTC
SL
MTCM
JAFL
AIM
FLAM
Chescapmanager's Q4 2019 Portfolio in Review
As of Q4 2019, Chescapmanager held 38 positions worth $680M, down 3.2% from $703M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Chescapmanager withdrew a net $76.3M in Q4 2019, closing 6 positions and reducing 4 holdings. Its most notable exit was Celgene Corp, an estimated $28.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Chescapmanager opened a new position in Tiffany & Co. worth $22.7M.
- Chescapmanager's largest Q4 2019 buy was Tiffany & Co.: 170,000 shares worth $22.7M.
- Chescapmanager added most to Theravance Biopharma in Q4 2019, an estimated $6.83M increase.
- Chescapmanager's biggest Q4 2019 reduction was Eagle Materials, cutting an estimated $10.2M.
- Chescapmanager fully exited Celgene Corp in Q4 2019, selling an estimated $28.4M.
- Chescapmanager's ten largest holdings make up 67% of its $680M portfolio in Q4 2019.
- Chescapmanager opened 6 new positions and closed 6 in Q4 2019.
- Chescapmanager's portfolio value fell 3.2% quarter-over-quarter to $680M.
Based on Chescapmanager's 13F filing for Q4 2019, filed 12 Feb 2020.